There is a lack of knowledge about drug-related problems among pregnant and lactating women.
In a new study, which was now featured in Dagens Medisin, Master's students of the PharmaSafe group questioned 212 Norwegian women in the maternity wards of two Norwegian hospitals. The authors report that 42% of these women have experienced drug-related problems during pregnancy.
The most common problem was the need for additional drugs and the most frequently affected drug group was drugs acting on the respiratory system. The authors conclude that many of the DRPs could be avoided by "providing patient-reported treatment reviews to pregnant women as a part of antenatal care."
Read more about the article in Dagens Medisin here.
The original scientific article can be found here.
In addition, the PharmaSafe group published another study in the journal Patient Education and Counseling.
The study with the title "Medication adherence among pregnant women with hypothyroidism − missed opportunities to improve reproductive health? A cross-sectional, web-based study" can be found here.